12.8335  -0.237 (-1.81%)		04-24 11:34
Open: 13.09 High: 13.3564 Volume: 12,742		Pre. Close: 13.07 Low: 12.76 Market Cap: 265(M)

Short term
Mid term
Targets	6-month :	16.93	1-year :	18.01
Resists	First :	14.49	Second :	15.42
Pivot price	14.4
Supports	First :	13	Second :	10.81
MAs	MA(5) :	13.7	MA(20) :	14.39
	MA(100) :	14.24	MA(250) :	0
MACD	MACD :	-0.2	Signal :	0
%K %D	K(14,3) :	5.1	D(3) :	15.3
RSI	RSI(14): 36
52-week	High :	17.23	Low :	10.92

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ SI ] has closed below the lower bollinger band by 1.6%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 33.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	13.82 - 13.92	13.92 - 13.99
Low:	12.79 - 12.91	12.91 - 13.01
Close:	12.9 - 13.07	13.07 - 13.2

Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.

Thu, 23 Apr 2026
Shoulder Innovations (SI) Stock: Investment Potential Insight | Q4 2025: EPS Misses Estimates - Market Buzz Alerts - UBND thành phố Hải Phòng

Wed, 22 Apr 2026
After the bell May 13, Shoulder Innovations sets Q1 earnings call - Stock Titan

Wed, 22 Apr 2026
Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026 - Yahoo Finance Singapore

Tue, 21 Apr 2026
COO at Shoulder Innovations (SI) exercises 21,664 stock options - Stock Titan

Tue, 14 Apr 2026
Shoulder Innovations (NYSE: SI) inks 10-year lease for new Michigan headquarters - Stock Titan

Tue, 10 Mar 2026
Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results - PR Newswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Specialties
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.